Co-occurrence of depression and chronic diseases
DOI:
https://doi.org/10.12775/JEHS.2023.13.04.026Keywords
depression, chronic disease, coexistence, public healthAbstract
INTRODUCTION
Depression is a common and serious mood disorder mainly manifested by sadness, anhedonia, lack of hope and interest in activities once enjoyed. According to WHO depression is a leading cause of disability and inability to work worldwide. Chronic disease is every condition lasting more than 1 year and requiring medical attention. The aim of this article is to show challenges of depression and chronic diseases coexistence.
DISCUSSION
Depression might be a factor causing difficulties in diagnosing chronic diseases as patients are less likely to cooperate. On the other it might lead to worse compliance and higher risk of chronic diseases’ development. Studies show depression coexisting with chronic illnesses is a valid problem for public health and aggravates the course and effects of treatment of those conditions. Treating an underlying disease is as important as treating depression itself as it might lead to reduction in symptoms of depression. Moreover doctors should choose drugs having regard to depression as well as lingering conditions.
SUMMARY
Depression still seems to be diminished and ignored in patients with chronic illnesses even though it is proved to have a destructive influence on the health of patients. It is of high importance to raise an awareness of doctors on that subject and its scale. There are plenty of treatment methods for depression in case of chronic diseases co-occurence which gives hope for improving a quality of life of patients and achieving better effects of therapy of an underlying disease.
References
Wojewódzka Stacja Sanitarno-Epidemiologiczna w Krakowie; Światowy Dzień Walki z Depresją 2021; https://www.gov.pl/web/wsse-krakow/swiatowy-dzien-walki-z-depresja-2021# (dostęp: 2022.12.18)
Centrala Narodowego Funduszu Zdrowia, Departament Analiz i Innowacji; NFZ o zdrowiu, depresja Warszawa; 2020 ISBN: 978-83-944034-9-2 (dostęp: 2022.12.18)
Stafford L, Berk M, Reddy P, Jackson HJ. Comorbid depression and health-related quality of life in patients with coronary artery disease. J Psychosom Res. 2007;62(4):401-10.
Mosivich SA, Boone RT, Reicheberg A, Bansilal S, Shaffer J, Dahlman K, Harvey PD, Farkouh ME, Nowe spojrzenie na związek między chorobami układu sercowo-naczyniowego a depresją. Folia Cardiologica Excerpta 2008;6–7(3):296–308.
Pająk A, Jankowski P, Kotseva K, Heidrich J, de Smedt D, De Bacquer D. Depression, anxiety, and risk factor control in patients after hospitalization for coronary heart disease: the EUROASPIRE III Study. Eur J Prev Cardiol. 2013;20(2):331–40.
Pietrzyk E, Gorczyca-Michta I, Michta K, Nowakowska M, Wożakowska-Kapłon B. Depresja u chorych po pomostowaniu aortalno-wieńowym; Psychiatr Pol. 2014 Sep-Oct;48(5):987-96
ICD-10, Międzynarodowa Statystyczna Klasyfikacja Chorób I Problemów Zdrowotnych, rewizja dziesiąta. Kraków-Warszawa 1997
Pełka-Wysiecka J, Samochowiec J; Depression-differentiated pharm/acotheraphy indeed, Psychiatria 2014;11(3):141-147
Murawiec S. Rozpoznawanie i leczenie depresji w praktyce lekarza POZ aspekty praktyczne; Centrum Terapii Dialog; 2017;5
Wciórka J. (red.). DSM IV-TR, Kryteria diagnostyczne według DSM IVTR. Wrocław 2008.
Whooley M, Avins A, Miranda J, Browner WS. Case-finding instruments for depression. Two questions are as good as many. J. Gen. Intern. Med.,1997;12:439−445.
Bernell S, Howard SW. Use Your Words Carefully: What Is a Chronic Disease? Front Public Health 2016;4:159
Weiss CO, Boyd CM, Yu Q, Wolff JL, Leff B. Patterns of Prevalent Major Chronic Disease Among Older Adults in the United States. JAMA. 2007;298(10):1158–62.
Noncommunicable disease https:/www.who.int/health-topics/noncommunicable-diseases (dostęp: 2022.12.18)
Naylor C, Parsonage M, McDaid D, Knapp M, Fossey M, Galea A. Long-term conditions and mental health: the cost of co-morbidities, The King’s Fund, 2012
Molarius A, Janson S. Self-rated health, chronic diseases, and symptoms among middle-aged and elderly men and women. J Clin Epidemiol. 2002;55(4):364–70.
Swain MG. Fatigue in chronic disease. Clin Sci. 2000;99(1):1–8
Alexopoulos GS. Depression in the elderly. The Lancet, 2005;365(9475):1961–1970.
Alexopoulos GS, Meyers BS, Young RC, Mattis S, Kakuma T. The course of geriatric depression with “reversible dementia”: a controlled study. Am J Psychiatry 1993;150:1693–99
Rakel RE. Depression. Primary Care: Clinics in Office Practice,1999;26(2):211–224.
Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and Pain Comorbidity. Archives of Internal Medicine, 2003;163(20):2433.
Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. European Journal of Pain, 2006;10:287– 333.
Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet, 2012;380(9836):37–43
Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol. Psychiatry, 2003;54:216-226.
Ziarko M, Mojs E, Piasecki B, Samborski W. The Mediating Role of Dysfunctional Coping in the Relationship between Beliefs about the Disease and the Level of Depression in Patients with Rheumatoid Arthritis. Scientific World J. 2014, 6.
Alexopoulos G.S, Raue PJ, Sirey JA, Arean PA. Developing an intervention for depressed, chronically medically ill elders: a model from COPD. Int. J. Geriatr. Psychiatry, 2008;23:447-453.
Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys, Lancet,2007;370:851–858.
Connollya MJ, Yohannesb AM. The impact of depression in older patients with chronic obstructive pulmonary disease and asthma, Maturitas, 2016 Oct;92:9-14
Hyman S, Chisolm D, Kessler R, Patel V, Whiteford H. Mental Disorders. In: Jamison DT, Mosley WH, Bobadilla JL, Measham AR, eds. Disease control priorities in developing countries, 2nd edn. New York: Oxford University Press; 2006.
Solomon DA, Keller MB, Leon AC, et al. Multiple recurrences of major depressive disorder. Am J Psychiatry 2000;157:229–233.
Zhang Y, Chen Y, Ma L. Depression and cardiovascular disease in elderly: Current understanding, J Clin Neurosci, 2018 Jan;47:1-5
Catalina-Romero C, Calvo-Bonacho E. Depression and cardiovascular disease: time for clinical trials. Atherosclerosis, 2017;257:250–252.
Lavoie KL, Bacon SL, Barone S, Cartier A, Ditto B, Labrecque M. What’s worse for asthma control and quality of life: depressive disorders, anxiety disorders, or both, Chest, 2006;130:1039–1047
Maurer J, Rebbapragada V, Borson S, Goldestin R, Kunik ME, Yohannes AM, Hanania NA, Anxiety and depression in COPD: current understanding, unanswered questions, and research needs Chest, 2008;134;43-56.
Pinquart M, Duberstein PR. Depression and cancer mortality: a meta-analysis, Psychol Med. 2010 Nov; 40(11): 1797–1810.
Ostuzzi G, Matcham F, Dauchy S, Barbui C, Hotopf M. Antidepressants for the treatment of depression in people with cancer, Cochrane Database Syst Rev, 2015 Jun 1;2015(6):CD011006
Arrieta O, Angulo LP, Núñez-Valencia C, Dorantes- Gallareta Y, Macedo EO, Martínez- López D, Alvarado S, Corona-Cruz JF, Oñate-Ocaña LF. Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Annals of Surgical Oncology 2013;20(6):1941–1948.
Colleoni M, Mandala M, Peruzzotti G, Robertson C, Bredart A, Goldhirsch A. Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet 2000;356 (9238):1326–1327
Prieto JM, Blanch J, Atala J, Carreras E, Rovira M, Cirera E, Gastó C. Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem- cell transplantation. Journal of Clinical Oncology 2002;20(7):1907–1917.
Zartaloudi A, Koutelekos I, Polikandrioti M, Stefanidou S, Koukoularis D, Kyritsi E, Anxiety and depression in primary care patients suffering of rheumatoid diseases, Psychiatriki, 2020;31(2):140-150
Fakra E, Marotte H, Rheumatoid arthritis and depression, Joint Bone Spine, 2021;88(5)
Andrews G. Should depression be managed as a chronic disease? BMJ 2001;322 419–421.
Wang JJ. Prevalence and correlates of depressive symptoms in the elderly of rural communities in southern Taiwan. J Nurs Res 2001;9:1–12.
Herrman H, Patrick DL, Diehr P, Martin ML, Fleck M, Simon GE, Buesching DP. Longitudinal investigation of depression outcomes in primary care in six countries: the LIDO study. Functional status, health service use and treatment of people with depressive symptoms. Psychol Med 2002;32:889–902.
Dudek D, Siwek M. Współistnienie chorób somatycznych i depresji. Psychiatria 2007;4(1):17-24
Samochowiec J, Dudek D, Kucharska-Mazur J, Murawiec S, Rymaszewska J, Cubała WJ, Heitzman J, Szulc A, Bała M, Gałecki P. Leczenie farmakologiczne epizodu depresji i zaburzeń depresyjnych nawracających – wytyczne Polskiego Towarzystwa Psychiatrycznego i Konsultanta Krajowego ds. Psychiatrii Dorosłych. Psychiatr. Pol. 2021; 55(2):235–259
Krawczyk P. Depresja w praktyce lekarza POZ – diagnostyka i farmakoterapia. Pediatr Med Rodz 2014;10(2):174–189
Stahl SM. Podstawy psychofarmakologii. Poradnik lekarza praktyka. Via Medica, Gdańsk, 2010.
Dudek D. Zaburzenia depresyjne i jakość życia u pacjentów z chorobą niedokrwienną serca poddanych zabiegom przezskórnej angioplastyki wieńcowej, Wydawnictwo Uniwersytetu Jagiellońskiego, 2005:132
Imiela T, Buda A. Znaczenie chorób towarzyszących i zespołu kruchości u chorych w podeszłym wieku z niewydolnością serca. Postępy Nauk Medycznych,2015, t. XXVIII, nr 11B, str. 26-31
O’Connor C.M., Jiang W., Kuchibhatla M, Mehta RH, Clary GL, Cuffe MS, Christopher EJ, Alexander JD, Califf RM, Krishnan RR, Antidepressant use, depression, and survival in patients with heart failure. Arch.Intern. Med., 2008;168: 2232–2237.
O’Connor CM, Jiang W, Kuchibhatla M, Silva SG, Cuffe MS, Callwood DD, Zakhary B, Gattis Stough W, Arias RM, Rivelli SK, Krishnan R, Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART- -CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 2010;56: 692-699.
Gottlieb SS, Kop WJ, Thomas SA, Katzen S, Vesely MR, Greenberg N, Marshall J, Cines M, Minshall S, A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure. Am Heart J, 2007;153:868-873.
Fraguas R, da Silva Telles RM, Alves TC, Andrei AM, Rays J, Iosifescu DV, Wajngarten M, A double-blind, placebo controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms. Contemp.Clin. Trials, 2009;30:205–211.
Frank D, Gruenbaum BF, Zlotnik A, Semyonov M, Frenkel A, Boyko M, Pathophysiology and Current Drug Treatments for Post-Stroke Depression: A Review, 202Int. J.Mol. Sci, 2;23:1511
de Groot M, Kushnick M, Doyle T, Merrill J, McGlynn M, Shubrook J, Schwartz F. Depression Among Adults With Diabetes: Prevalence, Impact, and Treatment Options. Diabetes Spectr. 2010;23(1);15-18.
Rybakowski J, Jaracz J, Nowakowska E. (red.) Inhibitory wychwytu zwrotnego serotoniny i noradrenaliny. Postępy farmakoterapii — nowe leki przeciwdepresyjne, Wydawnictwo Akademii Medycznej im. Karola Marcinkowskiego, Poznań, 2003:76–86.
Gołębiowski T, Augustyniak-Bartosik H, Weyde W, Klinger M, Zespoły geriatryczne u chorych na przewlekłą chorobą nerek, Postępy Higieny i Medycyny Doświadczalnej, 2016;70: 581-589.
Nagler EV, Webster AC, Vanholder R, Zoccali C, Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP). Nephrol Dial Transplant. 2012 Oct;27(10):3736-45.
Solvason HB, Battista C, Dawkowanie leków przeciwdepresyjnych w aktywnej fazie leczenia depresji w przebiegu nawracających zaburzeń depresyjnych, Psychiatria po Dyplomie, 2009;6(6):61-69.
Heitzman J, Solak M, Zespół odstawienia po lekach antydepresyjnych - problem dla lekarza i pacjenta, Psychiatria Polska;2007;5:601-613
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Zuzanna Fryska, Jakub Kuciński, Kacper Kulik, Krystian Matusz, Rafał Burczyk, Natalie Górna, Ewelina Mazurek, Adam Wołejko
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 540
Number of citations: 0
